Literature DB >> 28124008

Hepatocellular carcinoma (HCC) recurrence and what to do when it happens.

Adam S Bodzin1.   

Abstract

Entities:  

Year:  2016        PMID： 28124008      PMCID： PMC5218902          DOI： 10.21037/hbsn.2016.11.06

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  13 in total

1.  Predicting Mortality in Patients Developing Recurrent Hepatocellular Carcinoma After Liver Transplantation: Impact of Treatment Modality and Recurrence Characteristics.

Authors:  Adam S Bodzin; Keri E Lunsford; Daniela Markovic; Michael P Harlander-Locke; Ronald W Busuttil; Vatche G Agopian
Journal:  Ann Surg       Date:  2017-07       Impact factor: 12.969

2.  Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation.

Authors:  Roongruedee Chaiteerakij; Xiaodan Zhang; Benyam D Addissie; Essa A Mohamed; William S Harmsen; Paul J Theobald; Brian E Peters; Joseph G Balsanek; Melissa M Ward; Nasra H Giama; Catherine D Moser; Abdul M Oseini; Naoki Umeda; Sudhakar Venkatesh; Denise M Harnois; Michael R Charlton; Hiroyuki Yamada; Shinji Satomura; Alicia Algeciras-Schimnich; Melissa R Snyder; Terry M Therneau; Lewis R Roberts
Journal:  Liver Transpl       Date:  2015-05       Impact factor: 5.799

3.  The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence.

Authors:  B Ringe; C Wittekind; W O Bechstein; H Bunzendahl; R Pichlmayr
Journal:  Ann Surg       Date:  1989-01       Impact factor: 12.969

4.  Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.

Authors:  G Sapisochin; N Goldaracena; S Astete; J M Laurence; D Davidson; E Rafael; L Castells; C Sandroussi; I Bilbao; C Dopazo; D R Grant; J L Lázaro; M Caralt; A Ghanekar; I D McGilvray; L Lilly; M S Cattral; M Selzner; R Charco; P D Greig
Journal:  Ann Surg Oncol       Date:  2014-12-04       Impact factor: 5.344

5.  Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.

Authors:  John P Duffy; Andrew Vardanian; Elizabeth Benjamin; Melissa Watson; Douglas G Farmer; Rafik M Ghobrial; Gerald Lipshutz; Hasan Yersiz; David S K Lu; Charles Lassman; Myron J Tong; Jonathan R Hiatt; Ronald W Busuttil
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

6.  Liver transplantation for hepatocellular carcinoma: the Kyoto experience.

Authors:  Yasutsugu Takada; Shinji Uemoto
Journal:  J Hepatobiliary Pancreat Sci       Date:  2009-08-26       Impact factor: 7.027

7.  Meta-analysis of tumor recurrence after liver transplantation for hepatocellular carcinoma based on 1,198 cases.

Authors:  Georgios C Sotiropoulos; E P Molmenti; C Lösch; S Beckebaum; C E Broelsch; H Lang
Journal:  Eur J Med Res       Date:  2007-10-30       Impact factor: 2.175

8.  Long-term survival after recurrent hepatocellular carcinoma in liver transplant patients: clinical patterns and outcome variables.

Authors:  A Kornberg; B Küpper; A Tannapfel; K Katenkamp; K Thrum; O Habrecht; J Wilberg
Journal:  Eur J Surg Oncol       Date:  2009-10-25       Impact factor: 4.424

9.  Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis.

Authors:  Sasan Roayaie; Jonathan D Schwartz; Max W Sung; Sukru H Emre; Charles M Miller; Gabriel E Gondolesi; Nancy R Krieger; Myron E Schwartz
Journal:  Liver Transpl       Date:  2004-04       Impact factor: 5.799

10.  Factors predicting survival after post-transplant hepatocellular carcinoma recurrence.

Authors:  Christian Toso; Sonia Cader; Ariane Mentha-Dugerdil; Glenda Meeberg; Pietro Majno; Isabelle Morard; Emiliano Giostra; Thierry Berney; Philippe Morel; Gilles Mentha; Norman M Kneteman
Journal:  J Hepatobiliary Pancreat Sci       Date:  2013-03       Impact factor: 7.027
View more
  5 in total

1.  Impact of Preoperative Hepatitis B Virus Levels on Prognosis After Primary and Repeat Hepatectomies for Hepatocellular Carcinoma Patients-a Retrospective Study.

Authors:  Pin-Gao Yan; Ruo-Yu Wang; Jin Zhang; Wen-Ming Cong; Hui Dong; Hong-Yu Yu; Wan Yee Lau; Meng-Chao Wu; Wei-Ping Zhou
Journal:  J Gastrointest Surg       Date:  2018-01-08       Impact factor: 3.452

2.  An NIR-II/MR dual modal nanoprobe for liver cancer imaging.

Authors:  Ying Ren; Shuqing He; Lakshmi Huttad; Mei-Sze Chua; Samuel K So; Qiyong Guo; Zhen Cheng
Journal:  Nanoscale       Date:  2020-06-04       Impact factor: 7.790

3.  HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma.

Authors:  Wei-Min Wang; Yang Xu; Yao-Hui Wang; Hai-Xiang Sun; Yun-Fan Sun; Yi-Feng He; Qing-Feng Zhu; Bo Hu; Xin Zhang; Jing-Lin Xia; Shuang-Jian Qiu; Jian Zhou; Xin-Rong Yang; Jia Fan
Journal:  Oncotarget       Date:  2017-07-18

4.  Tumor microenvironment enhanced NIR II fluorescence imaging for tumor precise surgery navigation via tetrasulfide mesoporous silica-coated Nd-based rare-earth nanocrystals.

Authors:  Jiaqi Li; Fukai Zhu; Kangliang Lou; Haina Tian; Qiang Luo; Yongying Dang; Xiaolong Liu; Peiyuan Wang; Liming Wu
Journal:  Mater Today Bio       Date:  2022-08-20

5.  Statin use is associated with the reduction in hepatocellular carcinoma recurrence after liver surgery.

Authors:  Elias Khajeh; Arash Dooghaie Moghadam; Pegah Eslami; Sadeq Ali-Hasan-Al-Saegh; Ali Ramouz; Saeed Shafiei; Omid Ghamarnejad; Sepehr Abbasi Dezfouli; Christian Rupp; Christoph Springfeld; Carlos Carvalho; Pascal Probst; Seyed Mostafa Mousavizadeh; Arianeb Mehrabi
Journal:  BMC Cancer       Date:  2022-01-21       Impact factor: 4.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.